ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

YMAB Y mAbs Therapeutics Inc

17.25
0.76 (4.61%)
May 02 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 9.6M10.49M10.8M12.54M31.45M20.25M20.75M20.45M
Operating Income -35.76M-27.7M-39.95M-26.02M-1.19M-7.5M-7.22M-7.75M
Pre Tax Income -36.89M-28.07M-41.13M-27.53M1.12M-6.39M-6.12M-7.56M
Net Income -36.89M-28.07M-41.13M-27.53M1.12M-6.39M-6.12M-7.93M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -35.71M-28.07M-39.95M-26.02M-1.19M-7.5M-7.22M-7.75M
EBITDA -35.47M-27.5M-39.76M-25.79M-923k-7.32M-7M-7.58M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000020.75M34.9M65.27M84.82M
Operating Income -17.04M-19.24M-43.23M-83M-119.94M-115.43M-94.85M-25.67M
Pre Tax Income -17.06M-19.16M-43.27M-81.03M-119.34M-55.28M-95.61M-20.87M
Net Income -17.06M-19.16M-43.27M-81.03M-119.34M-55.28M-95.61M-21.43M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.211-0.988-1.266-2.04-2.933-1.265-2.189-0.491
EBIT -17.06M-19.16M-43.18M-80.99M-119.91M-53.38M-94.85M-25.67M
EBITDA -17.04M-19.24M-43.2M-82.84M-119.54M-114.65M-93.97M-24.94M

Your Recent History

Delayed Upgrade Clock